Forget AI: Billionaire Stanley Druckenmiller Likes This Insurance Stock

Druckenmiller's Stake: $23,842,000

Humana Inc. (NYSE:HUM) is simply a US wellness insurer focused chiefly connected Medicare Advantage plans for seniors. While the banal is up twelvemonth to day and has besides gained implicit the past year, it is down 28% implicit the past 5 years amid profitability unit successful the Medicare Advantage business.

The bull lawsuit for the agelong word is simple: the pressures are cyclical and partially fixable implicit time. Humana (NYSE:HUM) is targeting a instrumentality to astatine slightest a 3% Medicare Advantage borderline by 2028, suggesting absorption expects profitability to retrieve arsenic pricing, benefits, and utilization normalize. The institution besides expects net maturation to resume aft a 2026 "reset year," wherever existent pressures are absorbed and restructured into caller program designs and pricing.

Membership trends inactive supply immoderate support, with idiosyncratic Medicare Advantage rank expected to turn by astir 25% implicit 2026, driven by caller income and improved retention. This shows that contempt borderline pressure, request for the merchandise remains strong.

A cardinal further origin is activism. Glenview Capital has precocious taken a involvement successful Humana (NYSE:HUM). Glenview is an activistic capitalist known for pushing operational changes, outgo discipline, and strategical restructuring. Bulls reason that Glenview's engagement could assistance accelerate a turnaround successful execution and superior allocation, akin to however activism antecedently helped amended sentiment and show astatine CVS Health.

Artisan Value Fund stated the pursuing regarding Humana Inc. (NYSE:HUM) successful its Q1 2026 capitalist letter:

"Among the portfolio's biggest decliners were Salesforce, Accenture, Humana Inc. (NYSE:HUM) and PayPal Holdings, each of which dropped by 20% oregon much during the quarter. Managed attraction stocks, including Humana, besides declined during the quarter. The assemblage came nether unit aft the Centers for Medicare & Medicaid Services (CMS) released a preliminary 2027 Medicare Advantage complaint update that was importantly beneath expectations. The projected summation of conscionable 0.09% was fundamentally level compared with capitalist expectations of 4% to 6%. While last rates are often revised higher, the announcement was a meaningful disappointment and adds uncertainty to Humana's multiyear turnaround. More broadly, the managed attraction manufacture continues to look higher aesculapian costs driven by elevated utilization. Humana is besides dealing with little prime ratings nether the Medicare Stars program, which could trim bonus payments implicit the adjacent respective years. Although the banal appears inexpensive pursuing its caller decline, we chose to exit the presumption fixed the company's dense vulnerability to Medicare Advantage and the hazard that argumentation and execution challenges could hold a betterment successful margins and net (Click Here to Read the Letter successful Detail)."